NCT04246957|Completed
Quality of Life Comparison in Patients With Different Types of Alopecia
RDACCQV
Loading search results
RDACCQV
Sponsor study identifier
observational
100
1 country
1
Study Start
March 4, 2019
Actual (reported)Primary Completion
November 16, 2020
Actual (reported)Study Completion
November 16, 2020
Actual (reported)Hair loss is a frequent cause of patient consultation in dermatology. It is known to have a strong impact on patients' quality of life for many reasons; such as esthetic aspect, financial implications, social consequences. Numerous studies have assessed the impact of some types of alopecia on patients' quality of life. One study compared the quality of life in patients with scarring alopecia with patients of non-scarring alopecia. No studies have compared quality of life between the different types of scarring alopecia nor different types of non-scarring alopecia. However, none have assessed the impact on the patient partner quality of life. In addition, few treatments for alopecia are covered by national health insurance in France. The main objective is to compare the impact on the quality of life in different types of alopecia. By using the average scores of the questionnaire Dermatology Life Quality Index (DLQI) for each type of alopecia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 16, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 4, 2019
Actual (reported)January 21, 2020
Actual (reported)January 29, 2020
Actual (reported)November 16, 2020
Actual (reported)November 16, 2020
Actual (reported)Variation of score of questionnaire Dermatology Life Quality Index (DLQI) according alopecia type in patient life
The Dermatology life Quality Index (DLQI) is a ten-question questionnaire used to measure the impact of skin disease on the quality of life of an affected person. It is designed for people aged 16 years and above. There are 10 questions, covering the following topics: symptoms, embarrassment, shopping and home care, clothes, social and leisure, sport, work or study, close relationships, sex, treatment. Each question refers to the impact of the skin disease on the patient's life over the previous week. Each question is scored from 0 to 3, giving a possible score range form 0 (meaning no impact of skin disease on quality of life) to 30 (meaning maximum impact on quality of life).
at day 0
Variation of score of questionnaire Dermatology Life Quality Index (DLQI) according alopecia type in spouse life
at day 0
Every patient will have to fill out a general quality of life questionary : DLQI (Dermatology Life Quality Index)
Every patient will have to fill out a specific quality of life questionary : Hair Specific Skindex 29.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Every patient consulting in the dermatology department of Amiens' University Hospital for a primary alopecia will have to fill out 2 questionnaires of quality of life: one general (DLQI : Dermatology Life Quality Index) and one specific (Hair Specific Skindex 29). Every patient partner will have to complete one questionnaire of quality of life: FDLQI (Family DLQI).
CHU Amiens
Amiens, 80480, France
Catherine LOK, Pr
CHU Amiens
Thomas Baltazard, MD
CHU Amiens
Nesrine Zitouni, MD
CHU Amiens
Fanny Dessirier, MD
CHU Amiens
100 participants (actual enrollment reported by the registry).
First Submitted
January 21, 2020
First Posted
January 29, 2020
Study Start
March 4, 2019
Actual (reported)"Impact of a Programme to Improve Interaction Among Professionals on the Management of Task Interruptions"
Contact the study team to confirm eligibility.
Primary Completion
November 16, 2020
Actual (reported)Study Completion
November 16, 2020
Actual (reported)Last Updated
December 2, 2020
Record last verified: 2020-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: